Report Cover

Global Human Vaccine Market Insights and Forecast to 2027


Human Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
    Varicella
    Influenza
    Polio
    Hepatitis A
    Rabies
    BCG
    Hepatitis B
    Pertussis, Diphtheria, Tetanus
    Pneumococcal
    Rota vaccine

Segment by Application
    Adults
    Children

By Company
    CNBG
    Changsheng Life
    Zhifei
    ChengDa Bio
    Kangtai
    SINOVAC BIOTECH
    Hissen
    Walvax Biotechnology
    GSK
    SANOFI
    Rong An
    NuoCheng Bio
    Hualan Bio
    Tiantan biological
    Changchun Baike
    Adimmune
    Zhongyianke Biotech

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
1 Study Coverage
    1.1 Human Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Vaccine Market Size Growth Rate by Type
        1.4.2 Varicella
        1.4.3 Influenza
        1.2.4 Polio
        1.2.5 Hepatitis A
        1.2.6 Rabies
        1.2.7 BCG
        1.2.8 Hepatitis B
        1.2.9 Pertussis, Diphtheria, Tetanus
        1.2.10 Pneumococcal
        1.2.11 Rota vaccine
    1.3 Market by Application
        1.3.1 Global Human Vaccine Market Size Growth Rate by Application
        1.3.2 Adults
        1.3.3 Children
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Human Vaccine Sales Estimates and Forecasts 2016-2027
    2.2 Global Human Vaccine Revenue Estimates and Forecasts 2016-2027
    2.3 Global Human Vaccine Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Human Vaccine Regions by Sales
        2.4.1 Global Top Human Vaccine Regions by Sales (2016-2021)
        2.4.2 Global Top Human Vaccine Regions by Sales (2022-2027)
    2.5 Global Top Human Vaccine Regions by Revenue
        2.5.1 Global Top Human Vaccine Regions by Revenue (2016-2021)
        2.5.2 Global Top Human Vaccine Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Vaccine Sales by Manufacturers
        3.1.1 Global Top Human Vaccine Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Human Vaccine Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Human Vaccine Sales in 2020
    3.2 Global Human Vaccine Revenue by Manufacturers
        3.2.1 Global Top Human Vaccine Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Human Vaccine Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Human Vaccine Revenue in 2020
    3.3 Global Human Vaccine Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Human Vaccine Sales by Type
        4.1.1 Global Human Vaccine Historical Sales by Type (2016-2021)
        4.1.2 Global Human Vaccine Forecasted Sales by Type (2022-2027)
        4.1.3 Global Human Vaccine Sales Market Share by Type (2016-2027)
    4.2 Global Human Vaccine Revenue by Type
        4.2.1 Global Human Vaccine Historical Revenue by Type (2016-2021)
        4.2.2 Global Human Vaccine Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Human Vaccine Revenue Market Share by Type (2016-2027)
    4.3 Global Human Vaccine Price by Type
        4.3.1 Global Human Vaccine Price by Type (2016-2021)
        4.3.2 Global Human Vaccine Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Human Vaccine Sales by Application
        5.1.1 Global Human Vaccine Historical Sales by Application (2016-2021)
        5.1.2 Global Human Vaccine Forecasted Sales by Application (2022-2027)
        5.1.3 Global Human Vaccine Sales Market Share by Application (2016-2027)
    5.2 Global Human Vaccine Revenue by Application
        5.2.1 Global Human Vaccine Historical Revenue by Application (2016-2021)
        5.2.2 Global Human Vaccine Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Human Vaccine Revenue Market Share by Application (2016-2027)
    5.3 Global Human Vaccine Price by Application
        5.3.1 Global Human Vaccine Price by Application (2016-2021)
        5.3.2 Global Human Vaccine Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Human Vaccine Market Size by Type
        6.1.1 North America Human Vaccine Sales by Type (2016-2027)
        6.1.2 North America Human Vaccine Revenue by Type (2016-2027)
    6.2 North America Human Vaccine Market Size by Application
        6.2.1 North America Human Vaccine Sales by Application (2016-2027)
        6.2.2 North America Human Vaccine Revenue by Application (2016-2027)
    6.3 North America Human Vaccine Market Size by Country
        6.3.1 North America Human Vaccine Sales by Country (2016-2027)
        6.3.2 North America Human Vaccine Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Human Vaccine Market Size by Type
        7.1.1 Europe Human Vaccine Sales by Type (2017-2027)
        7.1.2 Europe Human Vaccine Revenue by Type (2017-2027)
    7.2 Europe Human Vaccine Market Size by Application
        7.2.1 Europe Human Vaccine Sales by Application (2017-2027)
        7.2.2 Europe Human Vaccine Revenue by Application (2017-2027)
    7.3 Europe Human Vaccine Market Size by Country
        7.3.1 Europe Human Vaccine Sales by Country (2017-2027)
        7.3.2 Europe Human Vaccine Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Vaccine Market Size by Type
        8.1.1 Asia Pacific Human Vaccine Sales by Type (2018-2027)
        8.1.2 Asia Pacific Human Vaccine Revenue by Type (2018-2027)
    8.2 Asia Pacific Human Vaccine Market Size by Application
        8.2.1 Asia Pacific Human Vaccine Sales by Application (2018-2027)
        8.2.2 Asia Pacific Human Vaccine Revenue by Application (2018-2027)
    8.3 Asia Pacific Human Vaccine Market Size by Region
        8.3.1 Asia Pacific Human Vaccine Sales by Region (2018-2027)
        8.3.2 Asia Pacific Human Vaccine Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Human Vaccine Market Size by Type
        9.1.1 Latin America Human Vaccine Sales by Type (2019-2027)
        9.1.2 Latin America Human Vaccine Revenue by Type (2019-2027)
    9.2 Latin America Human Vaccine Market Size by Application
        9.2.1 Latin America Human Vaccine Sales by Application (2019-2027)
        9.2.2 Latin America Human Vaccine Revenue by Application (2019-2027)
    9.3 Latin America Human Vaccine Market Size by Country
        9.3.1 Latin America Human Vaccine Sales by Country (2019-2027)
        9.3.2 Latin America Human Vaccine Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Human Vaccine Market Size by Type
        6.1.1 Middle East and Africa Human Vaccine Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Human Vaccine Revenue by Type (2016-2027)
    6.2 Middle East and Africa Human Vaccine Market Size by Application
        6.2.1 Middle East and Africa Human Vaccine Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Human Vaccine Revenue by Application (2016-2027)
    6.3 Middle East and Africa Human Vaccine Market Size by Country
        6.3.1 Middle East and Africa Human Vaccine Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Human Vaccine Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 CNBG
        11.1.1 CNBG Corporation Information
        11.1.2 CNBG Overview
        11.1.3 CNBG Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 CNBG Human Vaccine Product Description
        11.1.5 CNBG Related Developments
    11.2 Changsheng Life
        11.2.1 Changsheng Life Corporation Information
        11.2.2 Changsheng Life Overview
        11.2.3 Changsheng Life Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Changsheng Life Human Vaccine Product Description
        11.2.5 Changsheng Life Related Developments
    11.3 Zhifei
        11.3.1 Zhifei Corporation Information
        11.3.2 Zhifei Overview
        11.3.3 Zhifei Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Zhifei Human Vaccine Product Description
        11.3.5 Zhifei Related Developments
    11.4 ChengDa Bio
        11.4.1 ChengDa Bio Corporation Information
        11.4.2 ChengDa Bio Overview
        11.4.3 ChengDa Bio Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 ChengDa Bio Human Vaccine Product Description
        11.4.5 ChengDa Bio Related Developments
    11.5 Kangtai
        11.5.1 Kangtai Corporation Information
        11.5.2 Kangtai Overview
        11.5.3 Kangtai Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Kangtai Human Vaccine Product Description
        11.5.5 Kangtai Related Developments
    11.6 SINOVAC BIOTECH
        11.6.1 SINOVAC BIOTECH Corporation Information
        11.6.2 SINOVAC BIOTECH Overview
        11.6.3 SINOVAC BIOTECH Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 SINOVAC BIOTECH Human Vaccine Product Description
        11.6.5 SINOVAC BIOTECH Related Developments
    11.7 Hissen
        11.7.1 Hissen Corporation Information
        11.7.2 Hissen Overview
        11.7.3 Hissen Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Hissen Human Vaccine Product Description
        11.7.5 Hissen Related Developments
    11.8 Walvax Biotechnology
        11.8.1 Walvax Biotechnology Corporation Information
        11.8.2 Walvax Biotechnology Overview
        11.8.3 Walvax Biotechnology Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Walvax Biotechnology Human Vaccine Product Description
        11.8.5 Walvax Biotechnology Related Developments
    11.9 GSK
        11.9.1 GSK Corporation Information
        11.9.2 GSK Overview
        11.9.3 GSK Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 GSK Human Vaccine Product Description
        11.9.5 GSK Related Developments
    11.10 SANOFI
        11.10.1 SANOFI Corporation Information
        11.10.2 SANOFI Overview
        11.10.3 SANOFI Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 SANOFI Human Vaccine Product Description
        11.10.5 SANOFI Related Developments
    11.1 CNBG
        11.1.1 CNBG Corporation Information
        11.1.2 CNBG Overview
        11.1.3 CNBG Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 CNBG Human Vaccine Product Description
        11.1.5 CNBG Related Developments
    11.12 NuoCheng Bio
        11.12.1 NuoCheng Bio Corporation Information
        11.12.2 NuoCheng Bio Overview
        11.12.3 NuoCheng Bio Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 NuoCheng Bio Product Description
        11.12.5 NuoCheng Bio Related Developments
    11.13 Hualan Bio
        11.13.1 Hualan Bio Corporation Information
        11.13.2 Hualan Bio Overview
        11.13.3 Hualan Bio Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 Hualan Bio Product Description
        11.13.5 Hualan Bio Related Developments
    11.14 Tiantan biological
        11.14.1 Tiantan biological Corporation Information
        11.14.2 Tiantan biological Overview
        11.14.3 Tiantan biological Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.14.4 Tiantan biological Product Description
        11.14.5 Tiantan biological Related Developments
    11.15 Changchun Baike
        11.15.1 Changchun Baike Corporation Information
        11.15.2 Changchun Baike Overview
        11.15.3 Changchun Baike Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.15.4 Changchun Baike Product Description
        11.15.5 Changchun Baike Related Developments
    11.16 Adimmune
        11.16.1 Adimmune Corporation Information
        11.16.2 Adimmune Overview
        11.16.3 Adimmune Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.16.4 Adimmune Product Description
        11.16.5 Adimmune Related Developments
    11.17 Zhongyianke Biotech
        11.17.1 Zhongyianke Biotech Corporation Information
        11.17.2 Zhongyianke Biotech Overview
        11.17.3 Zhongyianke Biotech Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.17.4 Zhongyianke Biotech Product Description
        11.17.5 Zhongyianke Biotech Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Human Vaccine Value Chain Analysis
    12.2 Human Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Vaccine Production Mode & Process
    12.4 Human Vaccine Sales and Marketing
        12.4.1 Human Vaccine Sales Channels
        12.4.2 Human Vaccine Distributors
    12.5 Human Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Vaccine Industry Trends
    13.2 Human Vaccine Market Drivers
    13.3 Human Vaccine Market Challenges
    13.4 Human Vaccine Market Restraints

14 Key Findings in The Global Human Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables Table 1. Global Human Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Varicella Table 3. Major Manufacturers of Influenza Table 4. Major Manufacturers of Polio Table 5. Major Manufacturers of Hepatitis A Table 6. Major Manufacturers of Rabies Table 7. Major Manufacturers of BCG Table 8. Major Manufacturers of Hepatitis B Table 9. Major Manufacturers of Pertussis, Diphtheria, Tetanus Table 10. Major Manufacturers of Pneumococcal Table 11. Major Manufacturers of Rota vaccine Table 12. Global Human Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 13. Global Human Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 14. Global Human Vaccine Sales by Region (2016-2021) & (M Doses) Table 15. Global Human Vaccine Sales Market Share by Region (2016-2021) Table 16. Global Human Vaccine Sales by Region (2016-2021) & (M Doses) Table 17. Global Human Vaccine Sales Market Share by Region (2022-2027) Table 18. Global Human Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 19. Global Human Vaccine Revenue Market Share by Region (2016-2021) Table 20. Global Human Vaccine Revenue by Region (2022-2027) & (US$ Million) Table 21. Global Human Vaccine Revenue Market Share by Region (2022-2027) Table 22. Global Human Vaccine Sales by Manufacturers (2016-2021) & (M Doses) Table 23. Global Human Vaccine Sales Share by Manufacturers (2016-2021) Table 24. Global Human Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million) Table 25. Global Human Vaccine Revenue Share by Manufacturers (2016-2021) Table 26. Human Vaccine Price by Manufacturers 2016-2021 (USD/Dose) Table 27. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 28. Global Human Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine as of 2020) Table 29. Human Vaccine Manufacturing Base Distribution and Headquarters Table 30. Manufacturers Human Vaccine Product Offered Table 31. Date of Manufacturers Enter into Human Vaccine Market Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 34. Global Human Vaccine Sales by Type (2022-2027) & (M Doses) Table 35. Global Human Vaccine Sales Share by Type (2016-2021) Table 36. Global Human Vaccine Sales Share by Type (2022-2027) Table 37. Global Human Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 38. Global Human Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 39. Global Human Vaccine Revenue Share by Type (2016-2021) Table 40. Global Human Vaccine Revenue Share by Type (2022-2027) Table 41. Human Vaccine Price by Type (2016-2021) & (USD/Dose) Table 42. Global Human Vaccine Price Forecast by Type (2022-2027) & (USD/Dose) Table 43. Global Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 44. Global Human Vaccine Sales by Application (2022-2027) & (M Doses) Table 45. Global Human Vaccine Sales Share by Application (2016-2021) Table 46. Global Human Vaccine Sales Share by Application (2022-2027) Table 47. Global Human Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 48. Global Human Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 49. Global Human Vaccine Revenue Share by Application (2016-2021) Table 50. Global Human Vaccine Revenue Share by Application (2022-2027) Table 51. Human Vaccine Price by Application (2016-2021) & (USD/Dose) Table 52. Global Human Vaccine Price Forecast by Application (2022-2027) & (USD/Dose) Table 53. North America Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 54. North America Human Vaccine Sales by Type (2022-2027) & (M Doses) Table 55. North America Human Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 56. North America Human Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 57. North America Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 58. North America Human Vaccine Sales by Application (2022-2027) & (M Doses) Table 59. North America Human Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 60. North America Human Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 61. North America Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 62. North America Human Vaccine Sales by Country (2022-2027) & (M Doses) Table 63. North America Human Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 64. North America Human Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 65. Europe Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 66. Europe Human Vaccine Sales by Type (2022-2027) & (M Doses) Table 67. Europe Human Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 68. Europe Human Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 69. Europe Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 70. Europe Human Vaccine Sales by Application (2022-2027) & (M Doses) Table 71. Europe Human Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 72. Europe Human Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 73. Europe Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 74. Europe Human Vaccine Sales by Country (2022-2027) & (M Doses) Table 75. Europe Human Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 76. Europe Human Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 77. Asia Pacific Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 78. Asia Pacific Human Vaccine Sales by Type (2022-2027) & (M Doses) Table 79. Asia Pacific Human Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 80. Asia Pacific Human Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 81. Asia Pacific Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 82. Asia Pacific Human Vaccine Sales by Application (2022-2027) & (M Doses) Table 83. Asia Pacific Human Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 84. Asia Pacific Human Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 85. Asia Pacific Human Vaccine Sales by Region (2016-2021) & (M Doses) Table 86. Asia Pacific Human Vaccine Sales by Region (2022-2027) & (M Doses) Table 87. Asia Pacific Human Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 88. Asia Pacific Human Vaccine Revenue by Region (2022-2027) & (US$ Million) Table 89. Latin America Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 90. Latin America Human Vaccine Sales by Type (2022-2027) & (M Doses) Table 91. Latin America Human Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 92. Latin America Human Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 93. Latin America Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 94. Latin America Human Vaccine Sales by Application (2022-2027) & (M Doses) Table 95. Latin America Human Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 96. Latin America Human Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 97. Latin America Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 98. Latin America Human Vaccine Sales by Country (2022-2027) & (M Doses) Table 99. Latin America Human Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 100. Latin America Human Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 101. Middle East and Africa Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 102. Middle East and Africa Human Vaccine Sales by Type (2022-2027) & (M Doses) Table 103. Middle East and Africa Human Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 104. Middle East and Africa Human Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 105. Middle East and Africa Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 106. Middle East and Africa Human Vaccine Sales by Application (2022-2027) & (M Doses) Table 107. Middle East and Africa Human Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 108. Middle East and Africa Human Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 109. Middle East and Africa Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 110. Middle East and Africa Human Vaccine Sales by Country (2022-2027) & (M Doses) Table 111. Middle East and Africa Human Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 112. Middle East and Africa Human Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 113. CNBG Corporation Information Table 114. CNBG Description and Major Businesses Table 115. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 116. CNBG Human Vaccine Product Table 117. CNBG Recent Developments Table 118. Changsheng Life Corporation Information Table 119. Changsheng Life Description and Major Businesses Table 120. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 121. Changsheng Life Human Vaccine Product Table 122. Changsheng Life Recent Developments Table 123. Zhifei Corporation Information Table 124. Zhifei Description and Major Businesses Table 125. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 126. Zhifei Human Vaccine Product Table 127. Zhifei Recent Developments Table 128. ChengDa Bio Corporation Information Table 129. ChengDa Bio Description and Major Businesses Table 130. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 131. ChengDa Bio Human Vaccine Product Table 132. ChengDa Bio Recent Developments Table 133. Kangtai Corporation Information Table 134. Kangtai Description and Major Businesses Table 135. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 136. Kangtai Human Vaccine Product Table 137. Kangtai Recent Developments Table 138. SINOVAC BIOTECH Corporation Information Table 139. SINOVAC BIOTECH Description and Major Businesses Table 140. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 141. SINOVAC BIOTECH Human Vaccine Product Table 142. SINOVAC BIOTECH Recent Developments Table 143. Hissen Corporation Information Table 144. Hissen Description and Major Businesses Table 145. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 146. Hissen Human Vaccine Product Table 147. Hissen Recent Developments Table 148. Walvax Biotechnology Corporation Information Table 149. Walvax Biotechnology Description and Major Businesses Table 150. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 151. Walvax Biotechnology Human Vaccine Product Table 152. Walvax Biotechnology Recent Developments Table 153. GSK Corporation Information Table 154. GSK Description and Major Businesses Table 155. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 156. GSK Human Vaccine Product Table 157. GSK Recent Developments Table 158. SANOFI Corporation Information Table 159. SANOFI Description and Major Businesses Table 160. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 161. SANOFI Human Vaccine Product Table 162. SANOFI Recent Developments Table 163. Rong An Corporation Information Table 164. Rong An Description and Major Businesses Table 165. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 166. Rong An Human Vaccine Product Table 167. Rong An Recent Developments Table 168. NuoCheng Bio Corporation Information Table 169. NuoCheng Bio Description and Major Businesses Table 170. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 171. NuoCheng Bio Human Vaccine Product Table 172. NuoCheng Bio Recent Developments Table 173. Hualan Bio Corporation Information Table 174. Hualan Bio Description and Major Businesses Table 175. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 176. Hualan Bio Human Vaccine Product Table 177. Hualan Bio Recent Developments Table 178. Tiantan biological Corporation Information Table 179. Tiantan biological Description and Major Businesses Table 180. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 181. Tiantan biological Human Vaccine Product Table 182. Tiantan biological Recent Developments Table 183. Changchun Baike Corporation Information Table 184. Changchun Baike Description and Major Businesses Table 185. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 186. Changchun Baike Human Vaccine Product Table 187. Changchun Baike Recent Developments Table 188. Adimmune Corporation Information Table 189. Adimmune Description and Major Businesses Table 190. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 191. Adimmune Human Vaccine Product Table 192. Adimmune Recent Developments Table 193. Zhongyianke Biotech Corporation Information Table 194. Zhongyianke Biotech Description and Major Businesses Table 195. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 196. Zhongyianke Biotech Human Vaccine Product Table 197. Zhongyianke Biotech Recent Developments Table 198. Key Raw Materials Lists Table 199. Raw Materials Key Suppliers Lists Table 200. Human Vaccine Distributors List Table 201. Human Vaccine Customers List Table 202. Human Vaccine Market Trends Table 203. Human Vaccine Market Drivers Table 204. Human Vaccine Market Challenges Table 205. Human Vaccine Market Restraints Table 206. Research Programs/Design for This Report Table 207. Key Data Information from Secondary Sources Table 208. Key Data Information from Primary Sources List of Figures Figure 1. Human Vaccine Product Picture Figure 2. Global Human Vaccine Market Share by Type in 2020 & 2027 Figure 3. Varicella Product Picture Figure 4. Influenza Product Picture Figure 5. Polio Product Picture Figure 6. Hepatitis A Product Picture Figure 7. Rabies Product Picture Figure 8. BCG Product Picture Figure 9. Hepatitis B Product Picture Figure 10. Pertussis, Diphtheria, Tetanus Product Picture Figure 11. Pneumococcal Product Picture Figure 12. Rota vaccine Product Picture Figure 13. Global Human Vaccine Sales Market Share by Application in 2020 & 2027 Figure 14. Adults Figure 15. Children Figure 16. Human Vaccine Report Years Considered Figure 17. Global Human Vaccine Sales 2016-2027 (M Doses) Figure 18. Global Human Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 19. Global Human Vaccine Revenue 2016-2027 (US$ Million) Figure 20. Global Human Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 21. Global Human Vaccine Sales Market Share by Region (2016-2021) Figure 22. Global Human Vaccine Sales Market Share by Region (2022-2027) Figure 23. North America Human Vaccine Sales YoY (2016-2027) & (M Doses) Figure 24. North America Human Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 25. Europe Human Vaccine Sales YoY (2016-2027) & (M Doses) Figure 26. Europe Human Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 27. Asia-Pacific Human Vaccine Sales YoY (2016-2027) & (M Doses) Figure 28. Asia-Pacific Human Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 29. Latin America Human Vaccine Sales YoY (2016-2027) & (M Doses) Figure 30. Latin America Human Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 31. Middle East & Africa Human Vaccine Sales YoY (2016-2027) & (M Doses) Figure 32. Middle East & Africa Human Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 33. The Top 10 and Top 5 Players Market Share by Human Vaccine Sales in 2020 Figure 34. The Top 10 and Top 5 Players Market Share by Human Vaccine Revenue in 2020 Figure 35. Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 36. Global Human Vaccine Sales Market Share by Type (2016-2027) Figure 37. Global Human Vaccine Revenue Market Share by Type (2016-2027) Figure 38. Global Human Vaccine Sales Market Share by Application (2016-2027) Figure 39. Global Human Vaccine Revenue Market Share by Application (2016-2027) Figure 40. North America Human Vaccine Sales Market Share by Type (2016-2027) Figure 41. North America Human Vaccine Revenue Market Share by Type (2016-2027) Figure 42. North America Human Vaccine Sales Market Share by Application (2016-2027) Figure 43. North America Human Vaccine Revenue Market Share by Application (2016-2027) Figure 44. North America Human Vaccine Sales Share by Country (2016-2027) Figure 45. North America Human Vaccine Revenue Share by Country (2016-2027) Figure 46. U.S. Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 47. Canada Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 48. Europe Human Vaccine Sales Market Share by Type (2016-2027) Figure 49. Europe Human Vaccine Revenue Market Share by Type (2016-2027) Figure 50. Europe Human Vaccine Sales Market Share by Application (2016-2027) Figure 51. Europe Human Vaccine Revenue Market Share by Application (2016-2027) Figure 52. Europe Human Vaccine Sales Share by Country (2016-2027) Figure 53. Europe Human Vaccine Revenue Share by Country (2016-2027) Figure 54. Germany Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 55. France Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 56. U.K. Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 57. Italy Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 58. Russia Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 59. Asia Pacific Human Vaccine Sales Market Share by Type (2016-2027) Figure 60. Asia Pacific Human Vaccine Revenue Market Share by Type (2016-2027) Figure 61. Asia Pacific Human Vaccine Sales Market Share by Application (2016-2027) Figure 62. Asia Pacific Human Vaccine Revenue Market Share by Application (2016-2027) Figure 63. Asia Pacific Human Vaccine Sales Share by Region (2016-2027) Figure 64. Asia Pacific Human Vaccine Revenue Share by Region (2016-2027) Figure 65. China Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 66. Japan Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 67. South Korea Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 68. India Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 69. Australia Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 70. Taiwan Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 71. Indonesia Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 72. Thailand Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 73. Malaysia Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 74. Philippines Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 75. Latin America Human Vaccine Sales Market Share by Type (2016-2027) Figure 76. Latin America Human Vaccine Revenue Market Share by Type (2016-2027) Figure 77. Latin America Human Vaccine Sales Market Share by Application (2016-2027) Figure 78. Latin America Human Vaccine Revenue Market Share by Application (2016-2027) Figure 79. Latin America Human Vaccine Sales Share by Country (2016-2027) Figure 80. Latin America Human Vaccine Revenue Share by Country (2016-2027) Figure 81. Mexico Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 82. Brazil Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 83. Argentina Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 84. Middle East and Africa Human Vaccine Sales Market Share by Type (2016-2027) Figure 85. Middle East and Africa Human Vaccine Revenue Market Share by Type (2016-2027) Figure 86. Middle East and Africa Human Vaccine Sales Market Share by Application (2016-2027) Figure 87. Middle East and Africa Human Vaccine Revenue Market Share by Application (2016-2027) Figure 88. Middle East and Africa Human Vaccine Sales Share by Country (2016-2027) Figure 89. Middle East and Africa Human Vaccine Revenue Share by Country (2016-2027) Figure 90. Turkey Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 91. Saudi Arabia Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 92. U.A.E Human Vaccine Revenue (2016-2027) & (US$ Million) Figure 93. Human Vaccine Value Chain Figure 94. Human Vaccine Production Process Figure 95. Channels of Distribution Figure 96. Distributors Profiles Figure 97. Bottom-up and Top-down Approaches for This Report Figure 98. Data Triangulation Figure 99. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us